U.S. Hereditary Angioedema Association
Non-profit patient advocacy org. dedicated to providing wide-ranging services to patients
Based in HI
AI Overview
With $360K in lobbying spend across 36 quarterly filings, U.S. Hereditary Angioedema Association is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $40K |
| 2019 | $40K |
| 2020 | $50K |
| 2021 | $40K |
| 2022 | $40K |
| 2023 | $60K |
| 2024 | $50K |
| 2025 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that U.S. Hereditary Angioedema Association disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations
Patients' Access to Treatments Act
Follow on Biologics
Access to Marketplace Insurance
PFDDI @ FDA
Healthcare Reform, Patient Protections
Cost Sharing issues for life sustaining medicine
FY17 & FY18 L-HHS Appropriations Bills
FY17 & FY18 DoD Appropriations Bills
FY19 L-HHS Appropriations Bills
FY19 DoD Appropriations Bills
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.